Form 4 for IRMD IRADIMED CORP
Accepted 2022-12-08 00:00:00 ET · period of report 2022-12-06 · accession 0000898432-22-000656 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-08 | 2022-12-06+ | IRMD | HAWKINS JAMES B | Dir | A - Grant | $28.57 | +10.0K | 31.5K | +47% | +$285.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-06 | A | A | 5,000 | $28.55 | 26,490 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $28.45 to $28.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2022-12-07 | A | A | 5,000 | $28.58 | 31,490 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $28.48 to $28.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |